🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 128-week open-label study to assess the long-term safety and tole...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-30
Trial ID
NCT04084314
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-01
Trial ID
NCT00542308
Treatments Being Tested
Overall the study investigates organ crosstalk during exercise. More specif...
Status
Completed
Location
Rigshospitalet
Start Date
2024-04-09
Trial ID
NCT06334653
Treatments Being Tested
The goal of this clinical trial is to examine the proportion of patients wi...
Status
Not Yet Recruiting
Location
University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare
Start Date
2025-04-01
Trial ID
NCT06528392
Treatments Being Tested
This is a single center Phase I clinical trial of FT516 administered intrap...
Status
Completed
Location
University of Minnesota, Masonic Cancer Center
Start Date
2021-04-02
Trial ID
NCT04630769
Treatments Being Tested
The aim of this single-blind, randomized, experimental study was to investi...
Status
Completed
Location
Muğla Sıtkı Koçman University/Muğla Training and Research Hospital Endocrine and Metabolic Diseases Polyclinic
Start Date
2024-12-12
Trial ID
NCT07164079
Treatments Being Tested
TJ003234RAR101 is a first-in-human (FIH), single-center, randomized, double...
Status
Completed
Location
Pharmaron
Start Date
2019-03-18
Trial ID
NCT03794180
Primary Trial objectives: To evaluate the pharmacokinetics and -dynamics o...
Status
Completed
Location
ABX-CRO
Start Date
2009-10
Trial ID
NCT01043146
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Universitaetsklinik fuer Innere Medizin I
Start Date
2005-10
Trial ID
NCT00275054
Treatments Being Tested